Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Forum Bioscience Holdings

1980 FOUNDED
M&A STATUS
1-10 EMPLOYEES
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Supplier of pharmaceuticals. The company's pharmaceutical portfolio consist of active and supplementary ingredients in the area of veterinary medicine and APO-go, an active ingredient apomorphine, for the treatment of Parkinson's disease, enabling customers to receive the necessary medicines.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Primary Office
  • 41-51 Brighton Road
  • Redhill RH1 6YS
  • England, United Kingdom

Forum Bioscience Holdings Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Forum Bioscience Holdings‘s full profile, request access.

Request full access to PitchBook

Forum Bioscience Holdings Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Forum Bioscience Holdings‘s full profile, request access.

Request full access to PitchBook

Forum Bioscience Holdings Executive Team (1)

Name Title Board
Seat
Contact
Info
Peter Duckworth Managing Director & Co-Founder